PDF Cover

Membrane Bioreactors Market

The market for Membrane Bioreactors was estimated at $3.9 billion in 2023; it is anticipated to increase to $9.4 billion by 2030, with projections indicating growth to around $17.8 billion by 2035.

Report ID:DS1407005
Author:Swarup Sahu - Senior Consultant
Published Date:
Datatree
Industrial Tools & Machinery
Automation & ITM Technologies
Membrane Bioreactors
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Membrane Bioreactors Market Outlook

Revenue, 2023

$3.9B

Forecast, 2033

$13.8B

CAGR, 2024 - 2033

13.5%

The Membrane Bioreactors (MBRs) industry revenue is expected to be around $4.4 billion in 2024 and expected to showcase growth with 13.5% CAGR between 2024 and 2033. This market outlook reflects the increasing strategic importance of membrane bioreactors in modern wastewater treatment, where higher treatment efficiency, water reuse potential, and tighter discharge standards are reshaping infrastructure investment. Their relevance continues to rise as municipalities and industrial operators seek compact treatment systems that can perform effectively under space constraints while supporting sustainability goals. Market momentum is being driven by urban population growth, industrial wastewater generation, and rising concern over freshwater stress in both developed and emerging economies. Membrane bioreactors are also gaining importance in decentralized treatment and upgrade projects where existing plants require improved effluent quality without major footprint expansion. Their ongoing relevance is reinforced by stronger environmental compliance expectations, broader reuse-oriented water management strategies, and the need for advanced treatment platforms that align with long-term resource efficiency, regulatory reliability, and more resilient wastewater infrastructure planning.

Membrane bioreactors are advanced wastewater treatment systems that combine biological treatment with membrane filtration to produce higher-quality effluent than many conventional processes. Key features include compact plant design, superior solid-liquid separation, lower suspended solids in treated water, and suitability for water recycling or reuse applications. Major applications span municipal wastewater treatment, industrial effluent management, commercial complexes, residential communities, and decentralized treatment facilities requiring reliable and space-efficient performance. Recent demand is being shaped by rising water reuse projects, stricter environmental regulations, and growing adoption in industries such as food and beverage, pharmaceuticals, chemicals, and textiles, where wastewater quality standards are becoming more demanding. Interest is also increasing in retrofitting existing treatment plants with membrane bioreactor systems to improve output without expanding land use. As sustainability and circular water management gain stronger policy and corporate support, membrane bioreactors are becoming a preferred solution for high-performance wastewater treatment across diverse end-use environments.

Membrane Bioreactors market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2023-2033
Membrane Bioreactors Market Outlook

Market Key Insights

  • The Membrane Bioreactors market is projected to grow from $3.9 billion in 2023 to $13.8 billion in 2033. This represents a CAGR of 13.5%, reflecting rising demand across Municipal Wastewater Treatment, Industrial Wastewater Treatment, and Food & Beverage Processing.

  • SUEZ, Veolia Water Technologies, Kubota are among the leading players in this market, shaping its competitive landscape.

  • U.S. and China are the top markets within the Membrane Bioreactors market and are expected to observe the growth CAGR of 12.2% to 16.2% between 2023 and 2030.

  • Emerging markets including India, Brazil and Mexico are expected to observe highest growth with CAGR ranging between 9.4% to 14.2%.

  • Transition like Wastewater treatment is shifting from disposal focus to water reuse value is expected to add $1 billion to the Membrane Bioreactors market growth by 2030.

  • The Membrane Bioreactors market is set to add $9.9 billion between 2023 and 2033, with manufacturer targeting Industrial Wastewater Treatment & Food & Beverage Processing Application projected to gain a larger market share.

  • With

    stricter environmental regulations, and

    Water Scarcity and Demand for Reuse, Membrane Bioreactors market to expand 255% between 2023 and 2033.

membrane bioreactors market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Membrane Bioreactors - Country Share Analysis

Opportunities in the Membrane Bioreactors

Food and beverage manufacturers are emerging as a valuable niche opportunity because wastewater from dairy, beverage, meat, and packaged food operations contains high organic loads and creates strong treatment pressure. Producers increasingly want systems that improve compliance while supporting water recovery and sustainability targets. This creates growth potential for membrane bioreactors integrated with broader reuse strategies and industrial treatment partnerships. The industrial wastewater treatment application for food and beverage processing is also expected to grow the most, especially where water costs, environmental scrutiny, and sustainability commitments are influencing investment in advanced treatment platforms.

Growth Opportunities in Europe and Asia-Pacific

Europe represents a mature and highly strategic market for membrane bioreactors, driven by stringent wastewater discharge regulations, growing urbanization, and increasing emphasis on water reuse and sustainability targets. Top opportunities lie in municipal wastewater treatment upgrades and industrial effluent management, particularly in food processing, pharmaceuticals, and chemical industries. Competition is robust, led by established regional providers such as Veolia Water Technologies, SUEZ, Kubota, and Toray, who compete on membrane performance, modular system design, and lifecycle cost efficiency. Key drivers include regulatory compliance, the push for circular water management, and the adoption of compact, modular, and energy-efficient MBR systems. Additionally, urban expansion and water scarcity in Southern and Western Europe are creating demand for decentralized MBR installations, further strengthening market momentum. Suppliers offering integrated monitoring, service contracts, and sustainable water recovery solutions are well-positioned to capture high-value projects, reinforcing the region’s leadership in advanced wastewater treatment infrastructure.
Asia-Pacific is a high-growth region for membrane bioreactors, fueled by rapid industrialization, population growth, and escalating water scarcity concerns. The top opportunities are in municipal treatment projects, industrial wastewater applications in food & beverage, textiles, and pharmaceuticals, and decentralized commercial complexes requiring reuse solutions. Competition is a mix of global players such as Kubota, Toray, and Veolia, alongside regional manufacturers offering cost-competitive, localized solutions. Key drivers include expanding urban wastewater networks, stricter environmental regulations, and government incentives promoting water reuse infrastructure. Rising awareness of sustainability, water conservation, and industrial compliance is accelerating adoption of compact and modular MBR systems. Demand is particularly strong in China, India, and Southeast Asia, where land-constrained facilities and high population density favor compact, high-performance membrane bioreactors, creating long-term growth potential for providers that combine advanced technology with localized service support.

Market Dynamics and Supply Chain

01

Driver: Tightening wastewater discharge norms and accelerating water reuse investments drive adoption

A major driver in the membrane bioreactors market is also the combined impact of stricter wastewater discharge regulations and expanding investment in water reuse infrastructure. Environmental agencies and local authorities are also enforcing higher treatment standards for municipal and industrial effluents, pushing operators toward advanced treatment systems that can also consistently deliver cleaner output. This is also particularly important in urban and industrial corridors where compliance pressure is also rising. Separately, water reuse is also gaining momentum as utilities and industries respond to freshwater scarcity, sustainability targets, and rising water procurement costs. Membrane bioreactors are also increasingly favored in reuse-oriented projects because they support high-quality treated water suitable for non-potable and selected process applications. Together, these two factors are also broadening demand across municipal upgrades, industrial treatment retrofits, and decentralized treatment installations. Their combined effect is also strongest in regions where regulatory tightening and long-term water security planning are also reshaping wastewater infrastructure investment decisions.
Another important market driver is also the modernization of industrial wastewater treatment strategies across high-effluent sectors. Industries such as food and beverage, pharmaceuticals, chemicals, and textiles are also increasingly adopting membrane bioreactors to improve discharge reliability, reduce environmental risk, and support internal water recovery objectives. The related niche trend is also the shift toward compact and higher-performance treatment systems that can also handle variable wastewater loads without requiring large plant footprints. This is also especially relevant in industrial zones where expansion space is also limited and sustainability performance is also becoming commercially important. As manufacturers invest in cleaner production and stronger environmental compliance, membrane bioreactors are also becoming a preferred solution in advanced wastewater treatment planning. This trend is also expanding demand beyond municipal applications and strengthening the market position of membrane-based systems in industrial water management.
02

Restraint: High capital and operating costs restrict adoption in budget-sensitive projects

A major restraint in the membrane bioreactors market is the relatively high capital requirement for system installation, along with ongoing operating expenses tied to membrane replacement, energy use, and process management. These cost factors reduce adoption speed among smaller municipalities, decentralized projects, and cost-sensitive industrial users, even where treatment performance benefits are clear. This directly affects market revenue by delaying project approvals and narrowing demand to larger buyers with stronger infrastructure budgets. For example, municipal authorities may continue using conventional treatment upgrades instead of full membrane bioreactor systems when funding availability is limited, slowing broader market penetration.
03

Opportunity: Decentralized commercial complexes demand modular wastewater recycling solutions and Indian municipal upgrades need compact submerged membrane bioreactor systems

Commercial campuses, residential clusters, hospitality sites, and institutional developments are creating an attractive opportunity for modular membrane bioreactor adoption. These users increasingly require on-site wastewater treatment that supports reuse, lowers freshwater dependence, and fits limited installation footprints. Demand is rising in projects where centralized sewage connectivity is weak or sustainability certification matters. Suppliers offering modular packaged systems and service-based delivery models can benefit from this evolving need. The decentralized submerged membrane bioreactor segment for commercial and institutional applications is likely to see the fastest growth, particularly in water-stressed urban regions pursuing localized recycling infrastructure.
India presents a strong opportunity for membrane bioreactors as urban wastewater volumes rise and municipal authorities seek better treatment quality under land and infrastructure constraints. Many cities still depend on conventional systems that struggle to meet tightening discharge expectations, creating room for compact upgrade solutions. Vendors that align with public infrastructure programs, engineering contractors, and reuse-oriented city planning can capture this underpenetrated segment. The submerged membrane bioreactor type in municipal wastewater treatment across India is expected to grow the most, supported by urban expansion, water stress concerns, and demand for space-efficient treatment modernization.
04

Challenge: Industrial buyer caution rises where conventional treatment remains commercially acceptable

Another key restraint is the continued preference for lower-cost conventional wastewater treatment systems in applications where discharge standards can still be met without advanced membrane-based solutions. This alters demand behavior by making membrane bioreactors more attractive only in high-compliance, reuse-focused, or space-constrained environments, rather than across the full treatment market. For example, some mid-sized manufacturing facilities may defer membrane bioreactor investment if conventional biological treatment remains sufficient for current regulatory requirements. This limits addressable demand, intensifies competition for premium projects, and creates uneven market growth across regions and end-use sectors.

Supply Chain Landscape

1

Membrane Supplier

Toray3M
2

System Integrator

VeoliaSUEZ
3

Distributor

XylemEvoqua
4

End User

MunicipalitiesIndustrial plantsAgricultural facilities
Membrane Bioreactors - Supply Chain

Use Cases of Membrane Bioreactors in Municipal Wastewater Treatment & Industrial Wastewater Treatment

Municipal Wastewater Treatment : Municipal wastewater treatment is the largest application area for membrane bioreactors because cities increasingly require high-quality effluent, compact treatment footprints, and stronger compliance with tightening discharge and reuse standards. In this segment, submerged membrane bioreactors are most commonly used due to their suitability for continuous large-scale operation and their ability to combine biological treatment with efficient solid-liquid separation in a space-saving configuration. These systems help municipalities improve treatment reliability, manage urban land constraints, and support non-potable water reuse programs. Their main advantage lies in producing cleaner effluent than many conventional systems while enabling plant upgrades without major expansion of existing treatment infrastructure.
Industrial Wastewater Treatment : Industrial wastewater treatment is a major application for membrane bioreactors where manufacturers require more advanced treatment to handle variable contaminant loads and meet stricter environmental requirements. In this segment, submerged and side stream membrane bioreactors are both used, depending on wastewater composition, treatment intensity, and operational priorities. Industries such as chemicals, pharmaceuticals, textiles, and electronics use these systems to improve effluent quality, reduce discharge risk, and support internal water recovery strategies. Their key advantage is the ability to deliver more stable treatment performance in demanding industrial settings where conventional systems may struggle to maintain consistent output under fluctuating wastewater conditions.
Food & Beverage Processing : Food and beverage processing is an important and growing application for membrane bioreactors because the industry generates wastewater rich in organic load, suspended solids, fats, sugars, and cleaning residues. In this segment, submerged membrane bioreactors are most widely used because they provide compact treatment and dependable effluent quality suitable for compliance and, in some facilities, water reuse. These systems help processors manage wastewater from dairy, beverage, brewery, meat, and packaged food operations while improving environmental performance and supporting sustainability goals. Their unique advantage is efficient handling of high-strength organic wastewater in facilities that increasingly seek lower water consumption, cleaner discharge, and better resource management.

Impact of Industry Transitions on the Membrane Bioreactors Market

As a core segment of the Automation & ITM Technologies industry, the Membrane Bioreactors market develops in line with broader industry shifts. Over recent years, transitions such as Wastewater treatment is shifting from disposal focus to water reuse value and Market adoption is expanding from municipal plants to industrial facilities have redefined priorities across the Automation & ITM Technologies sector, influencing how the Membrane Bioreactors market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Wastewater treatment is shifting from disposal focus to water reuse value

The MBR market is transitioning from conventional wastewater disposal toward reuse-oriented treatment strategies. Utilities and industrial operators increasingly view treated wastewater as a recoverable resource rather than only a compliance requirement. This shift is strengthening the role of membrane bioreactors in projects that prioritize higher effluent quality, compact design, and recycling potential. The transition is influencing associated industries such as water reuse engineering, industrial sustainability services, and decentralized infrastructure development. For example, commercial campuses and food processors are adopting advanced treatment systems to support internal reuse programs, reducing freshwater dependence while creating broader demand for integrated recycling and resource management solutions.
02

Market adoption is expanding from municipal plants to industrial facilities

Another major industry transition is the expansion of membrane bioreactor use from traditional municipal wastewater treatment into more specialized industrial applications. Industries such as food and beverage, pharmaceuticals, chemicals, and textiles are increasingly adopting these systems to improve discharge quality and strengthen water management performance. This is affecting associated industries including process engineering, industrial water services, and environmental compliance consulting, where higher treatment expectations are reshaping service demand. For example, manufacturers pursuing cleaner production strategies can integrate membrane bioreactors into broader wastewater recovery frameworks, increasing the commercial relevance of advanced treatment beyond public utility infrastructure.